UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013347
Receipt number R000015577
Scientific Title Evaluation of thoracic epidural anesthesia on postoperative cardiac repolarization
Date of disclosure of the study information 2014/03/05
Last modified on 2023/09/12 22:00:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of thoracic epidural anesthesia on postoperative cardiac repolarization

Acronym

Thoracic epidural anesthesia on postoperative cardiac repolarization

Scientific Title

Evaluation of thoracic epidural anesthesia on postoperative cardiac repolarization

Scientific Title:Acronym

Thoracic epidural anesthesia on postoperative cardiac repolarization

Region

Japan


Condition

Condition

Patients scheduled for non-cardiac surgery under general anesthesia combined with thoracic epidural anesthesia

Classification by specialty

Surgery in general Anesthesiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Assessment of effects and safety of thoracic epidural anesthesia on postoperative cardiac repolarization

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

cardiac repolarization time on postoperative electrocardiography

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

intraoperative epidural administration of levobupivacaine

Interventions/Control_2

no intraoperative epidural administration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled for non-cardiac surgery under general anesthesia combined with thoracic epidural anesthesia

Key exclusion criteria

Patients taking medication that affects to QT interval, having any cardiac rhythm other than sinus rhythm, or with a preoprative abnormal QT prolongation

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Tadashi
Middle name
Last name Matsuura

Organization

Osaka City University Graduate School of Medicine

Division name

Department of Anesthesiology

Zip code

545-8586

Address

Asahimachi 1-5-7, Abenoku, Osaka 545-8586, Japan

TEL

+81-6-6645-2186

Email

t.matsuura@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name Kotaro
Middle name
Last name Hori

Organization

Osaka City University Graduate School of Medicine

Division name

Department of Anesthesiology

Zip code

545-8586

Address

Asahimachi 1-5-7, Abenoku, Osaka 545-8586, Japan

TEL

+81-6-6645-2186

Homepage URL


Email

k.hori@med.osaka-cu.ac.jp


Sponsor or person

Institute

Department of Anesthesiology, Osaka City University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research ethics committe, Osaka City University Graduate School of Medicine

Address

Asahimachi 1-2-7-601, Abenoku, Osaka

Tel

06-6645-3456

Email

ethics@med.osaka-cu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 03 Month 05 Day


Related information

URL releasing protocol

https://www.frontiersin.org/articles/10.3389/fphar.2023.936242/full

Publication of results

Unpublished


Result

URL related to results and publications

https://www.frontiersin.org/articles/10.3389/fphar.2023.936242/full

Number of participants that the trial has enrolled

60

Results

The median postoperative corrected QT interval interval with 3 ml/h epidural levobupivacaine was significantly longer than that without epidural analgesia. Using multiple regression analysis for the factors known to affect postoperative corrected QT interval interval, epidural analgesia was found to be an independent variable for prolongation, and the mean difference of the corrected QT interval interval with or without epidural analgesia was 23 ms after adjustment.

Results date posted

2023 Year 09 Month 12 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The median age of the patients was 71 (male/female 32/25), the medical history of whom were 4 coronary artery disease, 2 stroke and 17 diabets.The median surgical time was 224 min.

Participant flow

Patients were randomly allocated to two groups in a 1:1 ratio: an "Epidural Analgesia" group and a "No Epidural Analgesia" group. In both groups, an epidural catheter was inserted before induction of general anesthesia, but the epidural drug was administered only in the epidural analgesia group during surgery. The baseline QTc interval was recorded before the epidural tap, and postoperative QTc was recorded at the end of surgery following tracheal extubation.

Adverse events

None

Outcome measures

The postoperative QTc interval was used as the primary outcome to evaluate the potential risk of perioperative arrhythmogenicity.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 07 Month 04 Day

Date of IRB

2014 Year 03 Month 05 Day

Anticipated trial start date

2014 Year 03 Month 05 Day

Last follow-up date

2018 Year 12 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 03 Month 05 Day

Last modified on

2023 Year 09 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015577


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name